Page last updated: 2024-10-29

ketamine and Cancer of Pituitary

ketamine has been researched along with Cancer of Pituitary in 2 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Denson, DD1
Duchatelle, P1
Eaton, DC1
Hou, WY1
Lee, WY1
Lin, SM1
Liu, CC1
Susceto, L1
Sun, WZ1
Lin, SY1

Trials

1 trial available for ketamine and Cancer of Pituitary

ArticleYear
[The effects of ketamine, propofol and nitrous oxide on visual evoked potential during fentanyl anesthesia].
    Ma zui xue za zhi = Anaesthesiologica Sinica, 1993, Volume: 31, Issue:2

    Topics: Adult; Anesthesia, Intravenous; Evoked Potentials, Visual; Female; Fentanyl; Humans; Hypophysectomy;

1993

Other Studies

1 other study available for ketamine and Cancer of Pituitary

ArticleYear
The effect of racemic ketamine on the large conductance Ca(+2)-activated potassium (BK) channels in GH3 cells.
    Brain research, 1994, Feb-28, Volume: 638, Issue:1-2

    Topics: Analysis of Variance; Animals; Calcium; Cell Line; Charybdotoxin; Electrophysiology; Isomerism; Keta

1994